sclerosing cholangitis bpc 157 Xia & He Publishing Primary Sclerosing Cholangitis | Concise

You can still add Z91.81 as a secondary code, but it is not required

The pharmacy preparing it follows regulations to ensure the products quality

The capsule formulation compounded under 503A permits prescribers to individualize therapy across a broad microgram range-5 mcg to 50 mcg-allowing fine titration for pediatric patients, those with residual endogenous function, or individuals experiencing adverse effects at higher increments

It is typically inferred from plasma glycerol (glycerol cannot be re-used by the adipocyte, so its release tracks true lipolysis) or free-fatty-acid levels, or measured directly in adipose tissue or isolated adipocytes